Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

IPTC NewsCodes: 20000447

Cancer

Experimental monkey trapped in time-Titanium Media Official Website

  • Post date May 20, 2022 — 16:55 Post Lock Login to View

Read More

Many pharmaceutical companies clarified that the concept stock of Qianjintansu was on fire! Patent inventor responds to controversy with live broadcast_Oriental Fortune Network

  • Post date May 17, 2022 — 11:15 Post Lock Login to View

Read More

Qianjintansu concept stocks are on fire, and many pharmaceutical companies have clarified! Patent inventor responds to controversy live

  • Post date May 17, 2022 — 09:47 Post Lock Login to View

Read More

Qianjintansu concept stocks are on fire, and many pharmaceutical companies have clarified! Patent inventor responds to controversy with live broadcast in China Xinhua

  • Post date May 17, 2022 — 09:47 Post Lock Login to View

Read More

The inventor of the patent related to fenugreek: the fluctuation of the secondary market has nothing to do with us_Oriental Fortune Net

  • Post date May 17, 2022 — 09:36 Post Lock Login to View

Read More

Zhongheng Group: At present, the company's lung cancer drug anhydrous dulcitol for injection is in the process of listing.

  • Post date May 17, 2022 — 09:30 Post Lock Login to View

Read More

"Potential new crown special drug" Qianjintiansu was on fire, and many pharmaceutical companies clarified! Patent inventor responds to controversy – yqqlm

  • Post date May 17, 2022 — 09:19 Post Lock Login to View

Read More

Qianjintansu concept stocks are on fire, and many pharmaceutical companies have clarified! Patent inventor: secondary market volatility has nothing to do with us

  • Post date May 17, 2022 — 09:14 Post Lock Login to View

Read More

Qianjintansu concept stocks are on fire, and many pharmaceutical companies have clarified! The patent inventor responded live to the disputed Yunnan Baiyao injection.

  • Post date May 17, 2022 — 09:14 Post Lock Login to View

Read More

News|Laimei Pharmaceutical: Nano Carbon Iron Suspension Injection Approved for Clinical Trials_Medical_Sankei Channel Home_CAIJING.COM.CN

  • Post date May 17, 2022 — 02:56 Post Lock Login to View

Read More

How to become a nucleic acid testing company? -News Channel-Hexun.com

  • Post date May 17, 2022 — 00:41 Post Lock Login to View

Read More

Lamei Pharmaceutical's first anti-tumor drug received clinical trial approval

  • Post date May 16, 2022 — 23:17 Post Lock Login to View

Read More

Qianjin Pharmaceutical does not have Qianjin Tensudo to clarify the connection! Note that the inhibition data of 15,000 times the risk is only the result of in vitro experiments

  • Post date May 16, 2022 — 23:09 Post Lock Login to View

Read More

Qianjin Pharmaceutical has no Qianjin phylloxacin, and many companies clarify the relationship! Pay attention to the risks, the inhibition data of 15,000 times are only the results of in vitro experiments.

  • Post date May 16, 2022 — 23:07 Post Lock Login to View

Read More

Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation

  • Post date May 16, 2022 — 20:13 Post Lock Login to View

Read More

Potential Transaction Amount Over US$1.3 Billion Cologne Pharmaceuticals and Merck & Co. Reach an Oncology Drug Licensing Partnership Oncology

  • Post date May 16, 2022 — 20:07 Post Lock Login to View

Read More

Potential transaction value exceeds US$1.3 billion Kelun Pharmaceuticals and Merck & Co. reach an oncology drug authorization cooperation

  • Post date May 16, 2022 — 19:52 Post Lock Login to View

Read More

The 11th phase of HIBIO. Innovation Acceleration Camp ended with Chang Development helping innovative pharmaceutical companies to improve their R&D and drug registration levels-Business-Finance

  • Post date May 16, 2022 — 14:36 Post Lock Login to View

Read More

No clinical trials have yet been done on fenugreek, which claims to be the first in its ability to inhibit the new coronavirus

  • Post date May 15, 2022 — 11:10 Post Lock Login to View

Read More

The clinical trial of fenugreek, which claims to be the best in inhibiting the new coronavirus, has not been done yet-CFi.CN Zhongcai Network

  • Post date May 15, 2022 — 11:10 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.